Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Blast Injuries | 2 | 2017 | 20 | 1.39 | Why? |
| Burns | 2 | 2017 | 466 | 0.84 | Why? |
| Explosions | 2 | 2017 | 42 | 0.84 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2020 | 265 | 0.70 | Why? |
| Taiwan | 14 | 2020 | 2556 | 0.66 | Why? |
| Bacteremia | 2 | 2017 | 1372 | 0.62 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.59 | Why? |
| Drug Resistance, Bacterial | 4 | 2017 | 1414 | 0.58 | Why? |
| Complement System Proteins | 1 | 2018 | 380 | 0.54 | Why? |
| Epstein-Barr Virus Infections | 1 | 2018 | 366 | 0.52 | Why? |
| Endocarditis, Bacterial | 1 | 2018 | 344 | 0.51 | Why? |
| Endocarditis | 1 | 2018 | 368 | 0.50 | Why? |
| Urinary Tract Infections | 2 | 2017 | 534 | 0.46 | Why? |
| Urticaria | 1 | 2018 | 472 | 0.45 | Why? |
| Anti-Bacterial Agents | 9 | 2018 | 10083 | 0.45 | Why? |
| Vasculitis | 1 | 2018 | 691 | 0.43 | Why? |
| Klebsiella pneumoniae | 3 | 2017 | 658 | 0.33 | Why? |
| Shock, Septic | 1 | 2017 | 1313 | 0.33 | Why? |
| Minocycline | 2 | 2017 | 101 | 0.32 | Why? |
| Acinetobacter baumannii | 3 | 2018 | 378 | 0.30 | Why? |
| Pseudomonas aeruginosa | 3 | 2017 | 652 | 0.29 | Why? |
| Microbial Sensitivity Tests | 7 | 2018 | 2886 | 0.28 | Why? |
| Acinetobacter Infections | 2 | 2018 | 273 | 0.27 | Why? |
| Community-Acquired Infections | 1 | 2016 | 2328 | 0.27 | Why? |
| Drug Resistance, Multiple, Bacterial | 4 | 2018 | 1115 | 0.26 | Why? |
| Genes, Bacterial | 2 | 2017 | 207 | 0.22 | Why? |
| beta-Lactam Resistance | 2 | 2017 | 150 | 0.22 | Why? |
| Renal Dialysis | 1 | 2018 | 4358 | 0.22 | Why? |
| Immune Sera | 1 | 2005 | 884 | 0.21 | Why? |
| Staphylococcus aureus | 2 | 2017 | 844 | 0.21 | Why? |
| Biofilms | 2 | 2018 | 304 | 0.18 | Why? |
| Ralstonia pickettii | 1 | 2017 | 1 | 0.18 | Why? |
| Chryseobacterium | 1 | 2017 | 16 | 0.18 | Why? |
| Multidrug Resistance-Associated Proteins | 1 | 2017 | 29 | 0.17 | Why? |
| Imipenem | 1 | 2017 | 57 | 0.17 | Why? |
| Carbapenems | 2 | 2017 | 343 | 0.17 | Why? |
| Stenotrophomonas maltophilia | 1 | 2017 | 63 | 0.16 | Why? |
| Arthritis, Infectious | 1 | 2018 | 111 | 0.16 | Why? |
| Enterococcus | 1 | 2016 | 73 | 0.16 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2017 | 170 | 0.16 | Why? |
| Membrane Transport Proteins | 1 | 2017 | 152 | 0.15 | Why? |
| Trans-Activators | 1 | 2017 | 170 | 0.15 | Why? |
| Acetylcysteine | 1 | 2018 | 255 | 0.15 | Why? |
| Severe Acute Respiratory Syndrome | 4 | 2006 | 12361 | 0.14 | Why? |
| Prosthesis-Related Infections | 1 | 2018 | 302 | 0.14 | Why? |
| Blood Cell Count | 1 | 2020 | 1101 | 0.14 | Why? |
| Cephalosporins | 1 | 2016 | 250 | 0.14 | Why? |
| Enterobacteriaceae | 1 | 2016 | 395 | 0.12 | Why? |
| C-Reactive Protein | 2 | 2020 | 7972 | 0.12 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.12 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2017 | 398 | 0.12 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2021 | 1234 | 0.12 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.11 | Why? |
| High-Throughput Screening Assays | 1 | 2020 | 1783 | 0.11 | Why? |
| Bacterial Proteins | 2 | 2018 | 1318 | 0.11 | Why? |
| Platelet Count | 1 | 2017 | 1381 | 0.11 | Why? |
| Occupational Diseases | 1 | 2005 | 2787 | 0.10 | Why? |
| Immunization, Passive | 1 | 2005 | 10067 | 0.09 | Why? |
| Blood | 1 | 2010 | 274 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.09 | Why? |
| Retrospective Studies | 7 | 2018 | 105322 | 0.09 | Why? |
| Klebsiella Infections | 3 | 2017 | 466 | 0.09 | Why? |
| Male | 15 | 2021 | 367725 | 0.09 | Why? |
| Integrons | 1 | 2006 | 13 | 0.08 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.08 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.08 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2021 | 11367 | 0.08 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.08 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.08 | Why? |
| Diabetes Complications | 1 | 2018 | 2358 | 0.08 | Why? |
| Drug Evaluation, Preclinical | 1 | 2017 | 3347 | 0.08 | Why? |
| Cross Infection | 2 | 2018 | 8675 | 0.07 | Why? |
| Female | 13 | 2021 | 380317 | 0.07 | Why? |
| SARS Virus | 2 | 2006 | 13021 | 0.07 | Why? |
| Humans | 24 | 2021 | 930598 | 0.07 | Why? |
| Pneumonia | 2 | 2018 | 5652 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.06 | Why? |
| Adult | 9 | 2021 | 244371 | 0.06 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.06 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.06 | Why? |
| Hospitals | 4 | 2020 | 11793 | 0.06 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.05 | Why? |
| Blood Proteins | 1 | 2004 | 551 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.05 | Why? |
| beta-Lactamases | 1 | 2006 | 759 | 0.05 | Why? |
| Tuberculosis, Pulmonary | 1 | 2010 | 1171 | 0.05 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.05 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.05 | Why? |
| Tetracycline Resistance | 1 | 2017 | 8 | 0.05 | Why? |
| Electrophoresis, Gel, Pulsed-Field | 1 | 2017 | 78 | 0.04 | Why? |
| Severity of Illness Index | 1 | 2006 | 48226 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Ciprofloxacin | 1 | 2018 | 130 | 0.04 | Why? |
| Comorbidity | 2 | 2018 | 34796 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.04 | Why? |
| Reference Standards | 1 | 2020 | 1163 | 0.04 | Why? |
| Biological Transport | 1 | 2017 | 290 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.04 | Why? |
| Molecular Typing | 1 | 2017 | 280 | 0.04 | Why? |
| Fluoroquinolones | 1 | 2017 | 235 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2021 | 13720 | 0.04 | Why? |
| Sensitivity and Specificity | 3 | 2020 | 22971 | 0.04 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2017 | 214 | 0.04 | Why? |
| Intensive Care Units | 2 | 2018 | 29594 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Proteome | 1 | 2004 | 1812 | 0.03 | Why? |
| Drug Resistance, Microbial | 1 | 2018 | 419 | 0.03 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2017 | 27595 | 0.03 | Why? |
| Proteomics | 1 | 2004 | 2481 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 1439 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2018 | 403 | 0.03 | Why? |
| World Health Organization | 1 | 2006 | 4213 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.03 | Why? |
| Hospitals, General | 1 | 2017 | 711 | 0.03 | Why? |
| Cough | 1 | 2006 | 4891 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Patient Isolation | 1 | 2004 | 3182 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.02 | Why? |
| Fever | 1 | 2006 | 7795 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2005 | 9091 | 0.02 | Why? |
| Cytokines | 1 | 2010 | 15010 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.02 | Why? |
| Antigens, Bacterial | 1 | 2010 | 330 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2017 | 5814 | 0.02 | Why? |
| Hand Hygiene | 1 | 2017 | 1493 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Peroxiredoxins | 1 | 2004 | 13 | 0.02 | Why? |
| Peroxidases | 1 | 2004 | 20 | 0.02 | Why? |
| Republic of Korea | 1 | 2018 | 5858 | 0.02 | Why? |
| Electrophoresis, Gel, Two-Dimensional | 1 | 2004 | 40 | 0.02 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.02 | Why? |
| Lipopolysaccharides | 1 | 2010 | 848 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Japan | 1 | 2018 | 6653 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| In Situ Hybridization | 1 | 2006 | 390 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.02 | Why? |
| Acute-Phase Proteins | 1 | 2004 | 177 | 0.02 | Why? |
| Cloning, Molecular | 1 | 2006 | 1036 | 0.02 | Why? |
| Leukocytes | 1 | 2010 | 1046 | 0.02 | Why? |
| Hospitals, Military | 1 | 2004 | 205 | 0.02 | Why? |
| Caregivers | 1 | 2017 | 3112 | 0.01 | Why? |
| Infection Control | 2 | 2017 | 23131 | 0.01 | Why? |
| DNA, Bacterial | 1 | 2006 | 835 | 0.01 | Why? |
| DNA Primers | 1 | 2006 | 1170 | 0.01 | Why? |
| Pseudomonas Infections | 1 | 2006 | 425 | 0.01 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2005 | 21571 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2006 | 3198 | 0.01 | Why? |
| Lymphocyte Activation | 1 | 2010 | 2742 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.01 | Why? |
| Transportation of Patients | 1 | 2004 | 494 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.01 | Why? |
| Mass Spectrometry | 1 | 2004 | 1165 | 0.01 | Why? |
| Health Policy | 1 | 2018 | 6242 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Program Development | 1 | 2004 | 1089 | 0.01 | Why? |
| Base Sequence | 1 | 2006 | 3581 | 0.01 | Why? |
| ROC Curve | 1 | 2010 | 6024 | 0.01 | Why? |
| Ventilation | 1 | 2004 | 1145 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2010 | 7220 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2005 | 51949 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2004 | 6670 | 0.01 | Why? |
| Immunity, Innate | 1 | 2004 | 6570 | 0.00 | Why? |
| Prevalence | 1 | 2006 | 25773 | 0.00 | Why? |
| Time Factors | 1 | 2004 | 31397 | 0.00 | Why? |
Chang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(74)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_